CodeBreak 200: study limitations, and future directions

Transl Cancer Res. 2024 Jan 31;13(1):15-21. doi: 10.21037/tcr-23-1477. Epub 2024 Jan 5.

Authors

Malak Alharbi¹, Muhammad Awidi¹, Grace K Dy¹

Affiliation

¹ Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

No abstract available

Keywords: CodeBreak 200 (CB200); KRAS G12C; Non-small cell lung cancer (NSCLC); brain metastases; sotorasib.

Publication types

Editorial
Comment